The prevalence of face-lifts increased 8% between 2022 and 2023, a growth that the American Society of Plastic Surgeons links to Ozempic and Wegovy, according to a June 25 report from the organization.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis